Melleva

Ethinylestradiol, the active ingredient in Melleva, is a combined oral contraceptive presented as an oral tablet for oral use. It is formulated together with levonorgestrel to provide hormonal contraception for women of reproductive age, preventing unintended pregnancy through multiple mechanisms of action.

GNH USA supplies Melleva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from comprehensive regulatory support and consistent product availability across regions.

Melleva, a combined oral contraceptive, is used to prevent pregnancy by modulating the hormonal axis. - Contraception: prevents unintended pregnancy in women of reproductive age. - Cycle regulation: helps achieve more regular menstrual bleeding patterns. - Acne improvement: may reduce acne associated with hormonal fluctuations.

Melleva may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional throbbing or tension‑type pain. - Breakthrough bleeding: spotting between periods. - Weight change: slight increase or decrease in body weight. - Mood changes: irritability or mood swings.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins. - Arterial thrombosis: clot formation in arteries, potentially causing stroke. - Hypertension: elevated blood pressure. - Liver tumor: benign hepatic adenoma. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before prescribing Melleva, clinicians should consider several safety factors. - Assess cardiovascular risk: evaluate history of thrombosis before prescribing. - Avoid smoking: especially in women over 35 years of age. - Monitor blood pressure: check regularly during use. - Consider liver function: adjust if hepatic disease is present. - Review medication list: identify potential interactions. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Melleva can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): may reduce contraceptive effectiveness. - Rifampin: decreases hormone levels, increasing risk of unintended pregnancy. - Certain HIV protease inhibitors: may increase the risk of thrombosis.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may increase hormone concentrations. - St. John’s wort: may lower contraceptive effectiveness. - Antibiotics such as tetracycline: may slightly reduce absorption of the hormones.